Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Simulations Plus to Participate in BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference: https://mms.businesswire.com/media/20200318005128/en/780378/5/BusinessWireLogo.jpg
Simulations Plus to Participate in BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference


Simulations Plus, Inc. (Nasdaq: SLP), a premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, today announced that Shawn

Humana and IBM Watson Health Collaborate to Simplify and Enhance the Member Experience for Humana Employer Group Customers: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png
Humana and IBM Watson Health Collaborate to Simplify and Enhance the Member Experience for Humana Employer Group Customers


Humana Inc. (NYSE: HUM) and IBM (NYSE: IBM) Watson Health today announced a collaboration leveraging IBM’s conversational artificial intelligence (AI) solution – to help provide a better member

NanoString to Release Fourth Quarter and Fiscal Year 2020 Operating Results and Host Conference Call on Monday, March 1, 2021: https://mms.businesswire.com/media/20191104005218/en/753909/5/NSTG-Logo-19-%28002%29.jpg
NanoString to Release Fourth Quarter and Fiscal Year 2020 Operating Results and Host Conference Call on Monday, March 1, 2021


NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will release fourth quarter and

Humana Begins Coverage of Hospice Services as Part of Medicare Demonstration: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png
Humana Begins Coverage of Hospice Services as Part of Medicare Demonstration


Humana Inc. (NYSE: HUM) has begun evaluating a new way of offering hospice services to members of select Medicare Advantage plans in an attempt to provide greater continuity of care, additional

Waters Redefines Laboratory Science with New ACQUITY PREMIER Liquid Chromatography Solution
Waters Redefines Laboratory Science with New ACQUITY PREMIER Liquid Chromatography Solution


Waters Corporation (NYSE:WAT) today introduced the Waters™ ACQUITY™ PREMIER Solution, the next generation in liquid chromatographs featuring Waters’ breakthrough MaxPeak™ High Performance Surface

Illumina to Webcast Upcoming Investor Conference Presentations
Illumina to Webcast Upcoming Investor Conference Presentations


Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conferences and invited investors to participate via webcast.



SVB Leerink Annual Global

Impel NeuroPharma Partners With Veeva Systems to Build Integrated, Digital-First Commercial Foundation
Impel NeuroPharma Partners With Veeva Systems to Build Integrated, Digital-First Commercial Foundation


Impel NeuroPharma and Veeva Systems (NYSE: VEEV) today announced a strategic partnership as Impel continues advancing its pipeline of innovative medicines for central nervous system (CNS) diseases

STAAR Surgical to Report Fourth Quarter and Fiscal Year Results on February 24, 2021: https://mms.businesswire.com/media/20200413005098/en/683092/5/STAAR_Surgical_Logo_Primary_Lockup_%28Sunise_Teal%29.jpg
STAAR Surgical to Report Fourth Quarter and Fiscal Year Results on February 24, 2021


STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release

Simulations Plus Releases GastroPlus® Version 9.8.1: https://mms.businesswire.com/media/20200318005128/en/780378/5/BusinessWireLogo.jpg
Simulations Plus Releases GastroPlus® Version 9.8.1


Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries, today announced that it

Nature Medicine Publishes First Study Utilizing NanoString’s GeoMx Digital Spatial Profiler Whole Transcriptome Atlas
Nature Medicine Publishes First Study Utilizing NanoString’s GeoMx Digital Spatial Profiler Whole Transcriptome Atlas


NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the publication of a study in the journal Nature

Agilent to Present at Upcoming Investor Events; Provides Webcast Details for Annual Shareholder Meeting
Agilent to Present at Upcoming Investor Events; Provides Webcast Details for Annual Shareholder Meeting


Agilent Technologies Inc. (NYSE: A) today announced the following webcasts for the investment community.



10th Annual SVB Leerink Global Healthcare Conference
Wednesday, Feb. 24 at 7:40 a.m

Illumina Accelerator Invests in Nine Genomics Startups for Second Global Cycle
Illumina Accelerator Invests in Nine Genomics Startups for Second Global Cycle


Feb. 8, 2021 -- Illumina, Inc. (NASDAQ: ILMN) has selected nine new genomics companies to join the second global funding cycle of Illumina Accelerator in the U.S. and UK. The global company

ProvideGx® Partners with Apotex Corp. to Stabilize Supply of Three Vital Antibiotics: https://mms.businesswire.com/media/20191105005372/en/754182/5/PR_LogoSpec_%282%29.jpg
ProvideGx® Partners with Apotex Corp. to Stabilize Supply of Three Vital Antibiotics


Premier Inc. (NASDAQ: PINC), through its ProvideGx® program, has partnered with Apotex Corp. to supply three essential antibiotics to healthcare providers, helping to secure the immediate and

6 der 7 weltweit führenden Auftragsforschungsunternehmen kooperieren mit Veeva zur schnelleren Durchführung klinischer Studien für Sponsoren
6 der 7 weltweit führenden Auftragsforschungsunternehmen kooperieren mit Veeva zur schnelleren Durchführung klinischer Studien für Sponsoren


Veeva Systems (NYSE: VEEV) gab heute bekannt, dass sechs der sieben weltweit führenden Auftragsforschungsunternehmen dem Veeva Vault CDMS-Partnerprogramm beigetreten sind. Die Beschleunigung der

Lantheus Holdings Announces Presentations Featuring its PSMA-Targeted Pipeline Product Candidates at the 2021 ASCO GU Annual Meeting
Lantheus Holdings Announces Presentations Featuring its PSMA-Targeted Pipeline Product Candidates at the 2021 ASCO GU Annual Meeting


Lantheus Holdings, Inc. (NASDAQ: LNTH) (the “Company”), the parent company of Lantheus Medical Imaging, Inc. and Progenics Pharmaceuticals, Inc., and a global leader in the development, manufacture

6 of the Top 7 Global CROs Partner With Veeva to Run Faster Clinical Trials for Sponsors
6 of the Top 7 Global CROs Partner With Veeva to Run Faster Clinical Trials for Sponsors


Veeva Systems (NYSE: VEEV) today announced that 6 out of the top 7 global CROs have joined the Veeva Vault CDMS partner program. Accelerating clinical research is a top priority in the life

6 of the Top 7 Global CROs Partner with Veeva to Run Faster Clinical Trials for Sponsors
6 of the Top 7 Global CROs Partner with Veeva to Run Faster Clinical Trials for Sponsors


Veeva Systems (NYSE: VEEV) today announced that 6 out of the top 7 global CROs have joined the Veeva Vault CDMS partner program. Accelerating clinical research is a top priority in the life

Illumina Supports National Program to Evaluate Potential of Comprehensive Genomic Profiling in Late Stage Cancer Real-World Setting Across Belgium
Illumina Supports National Program to Evaluate Potential of Comprehensive Genomic Profiling in Late Stage Cancer Real-World Setting Across Belgium


February 4, 2021 -- Today, Illumina, Inc. (NASDAQ:ILMN) announced an agreement with the Belgian Society of Medical Oncology (BSMO) which is running a new national pilot to evaluate the use of

Epredia setzt Veeva MedTech-Lösungen zur Vereinheitlichung der Änderungskontrolle in den Bereichen Qualität und Regulierung ein
Epredia setzt Veeva MedTech-Lösungen zur Vereinheitlichung der Änderungskontrolle in den Bereichen Qualität und Regulierung ein


Veeva Systems (NYSE: VEEV) gab heute bekannt, dass Epredia, ein weltweit führender Anbieter im Bereich der Präzisionsdiagnostik für Krebs und Gewebe, die Anwendungen Veeva Vault Quality und Veeva

Quidel Opens New Manufacturing Facility to Mass Produce QuickVue® Rapid Antigen Tests for COVID-19
Quidel Opens New Manufacturing Facility to Mass Produce QuickVue® Rapid Antigen Tests for COVID-19


Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, today announced the opening

Chemed To Report Fourth-Quarter 2020 Earnings February 23, Related Conference Call To Be Held On February 24
Chemed To Report Fourth-Quarter 2020 Earnings February 23, Related Conference Call To Be Held On February 24


Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the fourth quarter ended December 31, 2020, on Tuesday, February 23, 2021, following the close of trading on

Epredia Adopts Veeva MedTech Solutions to Unify Change Control Across Quality and Regulatory
Epredia Adopts Veeva MedTech Solutions to Unify Change Control Across Quality and Regulatory


Veeva Systems (NYSE: VEEV) today announced that Epredia, a global leader in precision cancer and tissue diagnostics, is adopting Veeva Vault Quality and Veeva Vault RIM applications to automate

Epredia Adopts Veeva MedTech Solutions to Unify Change Control Across Quality and Regulatory
Epredia Adopts Veeva MedTech Solutions to Unify Change Control Across Quality and Regulatory


Veeva Systems (NYSE: VEEV) today announced that Epredia, a global leader in precision cancer and tissue diagnostics, is adopting Veeva Vault Quality and Veeva Vault RIM applications to automate

PerkinElmer Announces Financial Results for the Fourth Quarter and Full Year of 2020: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24701/263px-PerkinElmer.svg.png
PerkinElmer Announces Financial Results for the Fourth Quarter and Full Year of 2020


PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today reported financial results for the fourth quarter and full year ended January 3, 2021.



Fourth

Dexcom und Nick Jonas enthüllen den ersten Super Bowl-Werbespot und fordern eine bessere Versorgung von Menschen mit Diabetes
Dexcom und Nick Jonas enthüllen den ersten Super Bowl-Werbespot und fordern eine bessere Versorgung von Menschen mit Diabetes


DexCom, Inc. (NASDAQ:DXCM), der weltweit führende Anbieter von kontinuierlicher Blutzuckermessung für Menschen mit Diabetes, hat heute seinen allerersten Super-Bowl-Werbespot mit dem